Quest diagnostics reports second quarter 2022 financial results; raises guidance for full year 2022

Second quarter revenues of $2.45 billion, down 3.8% from 2021 second quarter reported diluted earnings per share ("eps") of $1.96, down 60.5% from 2021; and adjusted diluted eps of $2.36, down 25.8% from 2021 second quarter base business revenues of $2.10 billion, up 2.9% from 2021 full year 2022 reported diluted eps now expected to be between $8.24 and $8.64; and adjusted diluted eps expected to be between $9.55 and $9.95 secaucus, n.j. , july 21, 2022 /prnewswire/ -- quest diagnostics incorporated (nyse: dgx), the world's leading provider of diagnostic information services, announced today financial results for the second quarter ended june 30, 2022.
DGX Ratings Summary
DGX Quant Ranking